Sponsor

Merz Pharmaceuticals GmbH

Germany Eckenheimer Landstrasse 100, Nordend-West, 60318 Frankfurt, Germany

About the sponsor

Clinical research in lower limb spasticity associated with stroke and traumatic brain injury, with attention to motor impairment affecting gait and ankle function.

Adult spasticity
Ankle plantar flexor dysfunction
Post-stroke motor impairment
Traumatic brain injury-related spasticity

Interest is centered on therapeutic options for reducing muscle overactivity in the lower limbs.

About Specializations

Merz Pharmaceuticals GmbH runs clinical trials in conditions such as Paresis, Cerebral palsy, Muscle spasticity, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Quick filters

2 clinical trials

Paresis

Not recruiting

Registered drug

Study on the Effectiveness and Safety of NT 201 (Botulinum Toxin) for Treating Lower Limb Spasticity in Adults After Stroke or Traumatic Brain Injury

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
Sponsor:Merz Pharmaceuticals GmbH